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a b s t r a c t
This paper studies the impact of the location of a drug substance on the physicochemical and mechanical
properties of two types of calcium phosphate granules loaded with seven different contents of ibuprofen,
ranging from 1.75% to 46%. These implantable agglomerates were produced by either low or high shear
granulation. Unloaded Mi-Pro pellets presented higher sphericity and mechanical properties, but were
slightly less porous than Kenwood granules (57.7% vs 61.2%). Nevertheless, the whole expected quantity
of ibuprofen could be integrated into both types of granules. A combination of surface analysis, using
near-infrared (NIR) spectroscopy coupling chemical imaging, and pellet porosity, by mercury intrusion
measurements, allowed ibuprofen to be located. It was shown that, from 0% to 22% drug content, ibupro-
fen deposited simultaneously on the granule surface, as evidenced by the increase in surface NIR signal,
and inside the pores, as highlighted by the decrease in pore volume. From 22%, porosity was almost filled,
and additional drug substance coated the granule surfaces, leading to a large increase in the surface NIR
signal. This coating was more regular for Mi-Pro pellets owing to their higher sphericity and greater sur-
face deposition of drug substance. Unit crush tests using a microindenter revealed that ibuprofen loading
enhanced the mechanical strength of granules, especially above 22% drug content, which was favorable to
further application of the granules as a bone defect filler.
1. Introduction
Hard tissue diseases and defects, osteoporosis and osteoarthritis
have led to an extensive need for appropriate implantable materi-
als for bone replacement surgery. Among alternatives to bone
grafts, synthetic calcium phosphate based ceramics are widely
used [1,2] owing to their chemical composition close to the bone
mineral phase, which leads to high bone bonding ability [1,3–5].
Porous bioceramics have been developed to mimic the porous
architecture of trabecular bone. The advantage of the porous struc-
ture is that it provides appropriate space for bone ingrowth. In-
deed, when porosity is large enough (pore size > 100 lm), the
implanted material is progressively invaded and substituted by
bone tissue [6–9]. Bioceramics can also be drug loaded in order
to be used as delivery systems [10–13]. In this case, smaller pores
10 lm in diameter are intended to confine drug substances inside
the ceramic reservoir. By modulating the pore size and connec-
tions, adjustment of the release kinetics can be performed [14].
Previous work has shown that microporous calcium phosphate
pellets obtained by granulation followed by a calcination step
can be loaded with ibuprofen [15–17]. This physical presentation
(spherical implants 900 lm in diameter) allows the filling of
complex-shaped bone defects rather than blocks, while keeping
regular macroporosity (intergranular spaces 180 lm) necessary
for bone ingrowth. Such spherical granules are also interesting
for drug delivery applications, as their controlled surface allows
the deposition of regular and reproducible amounts of therapeutic
agents. The choice of ibuprofen was directed by the fact that this
anti-inflammatory agent, already associated with bone implants
(bioactive glass-polymer [18] and hydroxyapatite [19]), could con-
tribute to the local treatment of inflammation [20,21] following
surgery or to the treatment of bone loss in periodontitis [22].
Moreover, this drug substance has been used extensively as a mod-
el drug in the development of sustained and controlled drug deliv-
ery systems [23–26] because of its short biological half-life.
The physicochemical, textural and dissolution properties of
these ibuprofen-containing pellets allow them to be considered
as drug delivery systems [15–17,27,28]. Nevertheless, complete
characterization, including considerations of the mechanics and
location of the drug substance, is required to evaluate the end-
use properties of the granules.
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The usual functionality tests (packing measurements, flow rate
measurements, diametral compression test after granule compac-
tion, friability measurements) characterize the global and averaged
properties of large particulate populations. However, unitary tests
on individual granules may be useful when only small amounts of
products are available, provided they represent the whole sample
properties, and to evidence inter-individual variations that may
be hidden in the case of global tests.
Concerning the mechanical properties of granules, various tests
can be carried out, such as friability measurements, uniaxial com-
pression between two parallel plates, impact against a surface and
indentation methods [29–32]. Standard friability measurement is
always performed on granule samples; impact against a surface
and indentation methods are carried out on individual agglomer-
ates, whereas uniaxial compression can be conducted either on a
whole sample or on individual granules. In the latter case, not only
average strength is determined, but variations between single
agglomerates can also be expressed from the weakest and the
strongest values [33]. In this study, the granule mechanical proper-
ties were determined using a single-granule crush test carried out
with a microindenter and compared with friability measurements.
The development of innovative drug delivery systems in phar-
maceutical and biomaterial fields requires the use of new tech-
niques to investigate and control these products. Methods such
as spectrometry, chromatography, colorimetry, refractometry, X-
ray diffraction, solid nuclear magnetic resonance and mass spec-
trometry are performed to identify and, for some of these, to assay
the drug substances. Other techniques have been developed to
characterize the layered structures. However, most of them are
unspecific (e.g., weight gain during coating) or destructive (e.g.,
electron microscopy of cross sections) [34,35] and do not allow
precise location of the drug substances. In contrast, Raman and
near-infrared (NIR) spectroscopy are rapid and non-destructive
methods that require no sample preparation [36,37]. Moreover,
they are useful for both rapidly quantifying and locating drug sub-
stances. In the present work, NIR spectroscopy coupling chemical
imaging (NIR-CI) and image analysis are tested in order to map
the drug substance associated with calcium phosphate granules.
Two types of granules, produced by low and high shear granu-
lation, loaded with various ibuprofen contents are compared. This
paper aims to study the impact of drug substance location on the
physicochemical and mechanical properties of ceramic pellets, by
combining several characterization methods.
2. Materials and methods
2.1. Materials
Porous calcium phosphate granules were fabricated by either
low shear (Kenwood, model KM201, Kenwood Ltd., UK) or high
shear wet granulation (Mi-Pro, Pro-C-epT, Zelzate, Belgium) as de-
scribed in previous work [15–17]. Calcium phosphate (Batch No.
G8138/3, Cooper, France) was granulated with pregelatinized
starch (Sepistab ST 200, batch number 80551, Seppic, France) also
acting as a pore former after removal by heat treatment. The 710–
1000-lm fraction of porous granules was drug loaded with an eth-
anolic ibuprofen solution by solvent evaporation in a Rotavapor
(Büchi, Switzerland). Seven percentages of drug content were
tested: 1.75%, 3.5%, 7%, 12.5%, 22%, 36% and 46%.
2.2. Methods
2.2.1. Morphological evaluation
Unloaded and loaded granule morphology was observed by
scanning electron microscopy (SEM; Stereoscan S260, Leica, Cam-
bridge, UK) after Au/Pd metallization.
An automated particle imaging system (Morphologi G3, Mal-
vern Instruments, Malvern, UK) was used to measure the size
and shape parameters of a large number of granules per batch
(more than 200). High sensitivity circularity (HSC) is defined as:
HSC ¼ circularity2 ¼ 4p area
perimeter2
HSC is more sensitive than circularity for comparing particles of
similar morphology. The HSC of a sphere equals 1.
2.2.2. Specific surface area measurement
The specific surface area (Sspe, m2 g1) of the unloaded granules
was determined by nitrogen adsorption using a Gemini 2360 Ana-
lyzer (Micromeritics Instruments Inc., Norcross, GA). Prior to mea-
surements, samples were degassed for three days at room
temperature under a 50 mTorr vacuum (VacPrep 061, Micromeri-
tics Instruments Inc., Norcross, GA). The specific surface area was
calculated by the BET multipoint equation [38]. The sample weight
was adjusted to ensure a surface of at least 1 m2 in the cell. Mea-
surements were repeated until the value was stabilized.
2.2.3. Density measurements
The pycnometric density (dpycno, g cm3) of raw materials and
granules before and after loading was determined using an Accu-
Pyc 1330 helium pycnometer (Micromeritics Instruments Inc.,
Norcross, GA) [39]. The samples were previously degassed under
the same conditions as for specific surface area measurements.
Measurements were repeated until stabilization.
Theoretical density (dpycno theo) could be calculated by taking
into account the weight fraction of each constituent (an) and their
respective measured pycnometric density (dn) according to the fol-
lowing equation:
dpycno theo ¼ 1½ðaa=daÞ þ ðab=dbÞ ð1Þ
Bulk (dbulk, g cm3) and packed (dpacked, g cm3) densities were
determined in triplicate, using a 1 cm3 cell according to:
dbulk ¼ mV0 ð2Þ
dpacked ¼ mV0:5 ð3Þ
where m is the mass of the granule sample freely poured into the
cell, V0 is the corresponding volume (1 cm3) and V0.5 is the volume
occupied by granules under a uniaxial pressure of 0.5 MPa (Lloyd
Instrument LR30K, Fareham, UK). This pressure corresponded to
the packing and slippage of the particles without any deformation
[40].
2.2.4. Porosity investigation
Porosity measurements were performed using a mercury intru-
sion porosimeter (Autopore IV 9500, Micromeritics Instruments
Inc., Norcross, GA) with a 5 cm3 powder penetrometer. Mercury
intrusion volumes were recorded. The intergranule porosity was
not considered here as it was only partially measured owing to
mercury porosimetry limitations in the case of large spaces. Only
the intragranule porosity (pellet porosity, %) was calculated
according to:
Pellet porosity ¼ V intra
V solid þ V intra  100 ð4Þ
where Vsolid, the solid volume of the granules, is deduced from the
pycnometric measurements, and Vintra is the porous volume of the
granules.
2.2.5. Mechanical properties
2.2.5.1. Friability measurement. Friability measurements were per-
formed on 10 g of unloaded granules which were introduced into
a glass container [41]. They were subjected to horizontal oscilla-
tions (240 oscillations min1 for 240 s) in an oscillating apparatus
(Friabimat, GTA-120, Erweka, Heusenstamm, Germany). After siev-
ing through a 710 lm sieve to remove fine particles, granules were
weighed, and the friability (F, %) was calculated according to the
following equation:
F ¼ m1 m2
m1
 100 ð5Þ
where m1 is the mass of granules before the test (10 g), and m2 is
the mass of granules retained by the sieve after the test. The test
was performed in triplicate.
2.2.5.2. Granule crush test. A unit crush test was performed on the
granules before and after ibuprofen loading by instrumented
indentation using a Micro Hardness Tester (MHT, CSM Instru-
ments, Peseux, Switzerland). A stainless steel punch 2 mm in diam-
eter, normal to the pellet surface, was linearly driven into the
granule by applying an increasing load up to the breaking of the
granule. The maximal load of the sensor was 30 N, and the load
resolution was 0.3 mN. The test was performed on about 10 gran-
ules. The contact force detection between the steel punch and the
granule was 10 mN.
2.2.6. NIR chemical imaging
Ibuprofen location on calcium phosphate granules was studied
using a NIR-CI system [42–44]. SyNIRgi apparatus (Malvern Instru-
ments, Malvern, UK) equipped with a focal plane array detector
(320  256 pixels) was used in this work. Spectra were collected
from 1200 to 2400 nm in 10 nm increments and 16 co-additions.
Two magnifications were used for this work: the field of view
was set to 12.8  10.2 mm, providing a pixel magnification of
40 lm for parallel imaging of multiple granules, while a magnifica-
tion of 8.1 lm per pixel was used to investigate individual gran-
ules. All data were acquired in diffuse reflectance, a process by
which the source radiation interacts with the surface of the sam-
ple, and the radiation diffusely reflected in the direction of the
camera is measured. Dark and bright background image cubes
were acquired at initiation, followed by successive sample cubes.
For each sample scanned, 81,920 spectra were collected in
2 min to form a so-called data cube, in which the x- and y-axes
correspond to the physical location of the pixel, and the z-axis con-
tains the spectral data.
All data were analyzed with ISys 5.0 Data Analysis Software
(Malvern Instruments, Malvern, UK). Sample data were converted
to absorbance (A) according to the following equation:
A ¼ log 1=R ð6Þ
where R was the reflectance obtained by processing the sample (S),
dark (D) and background (B) image cubes as follows:
R ¼ S D
B D ð7Þ
At the same time, a spectral reference library was created by
collecting images of pure ibuprofen and calcium phosphate
granules.
NIR-CI benefits from the chemical specificity of NIR spectros-
copy and the spatial resolution of a two-dimensional camera im-
age. In this particular case, the distribution of ibuprofen will be
mapped on calcium phosphate granules provided their respective
NIR spectra do not overlap. It was possible to investigate the chem-
ical composition of a few granules at high magnification to gain an
understanding of the spatial location of the components. A low
magnification can also be selected to image a large number of
granules for comparison of overall surface drug load or to investi-
gate the distribution of components inside the cross sections of
granules.
3. Results and discussion
3.1. Influence of granulation on granule properties
Table 1 summarizes the physicochemical characteristics of the
granules before drug loading. The granules are called Kenwood
granules when obtained with Kenwood equipment and Mi-Pro
granules when produced with Mi-Pro.
Pycnometric densities of Kenwood and Mi-Pro granules were
similar before loading, confirming that the heat treatment, remov-
ing the pore former, led to a similar CaP matrix whatever the gran-
ulation process.
In contrast, the bulk density distinguished the two types of
granules: Mi-Pro high shear conferred a higher bulk density to
the pellet bed (0.71 g cm3 vs 0.55 g cm3). As the specific surface
area and particle size distribution of Kenwood and Mi-Pro granules
were relatively similar, the bulk density difference might be attrib-
uted to their respective morphology (microscopic observations and
circularity coefficient) and porosity, both responsible for closer ini-
tial packing of Mi-Pro pellets. For this reason, Mi-Pro pellets would
be better candidates for bone defect filling, even though packed
densities showed that the same compacity (0.78–0.79 g cm3)
might be reached at low pressure (0.5 MPa) for both types of gran-
ules. In fact, as both bulk and packed densities of Mi-Pro pellets
were close, pellets would more easily rearrange into the bone de-
fect under the pressure applied by the surgeon to fill the cavity
completely.
Moreover, Mi-Pro pellet friability was lower than that of the
Kenwood granule: 12.1% and 21.3%, respectively. This value was
in accordance with the lower porosity and the more spherical
shape previously observed. As this test considered granules rolling
and impacting on each other, the friability resulted from both the
surface state attrition ability and the intrinsic mechanical strength
of the granules. Consequently, it can be assumed that the particles
constituting the Mi-Pro pellets presented higher cohesion due to
the high densification involved during the granulation process.
Granule crush test confirmed this assumption, as the individual
strength of Mi-Pro pellets was more than twice as high as the Ken-
wood granule one (respectively, 750 ± 225 mN and 298 ± 97 mN).
Hereafter, only this mechanical test will be performed to charac-
terize the loaded granules, as it required fewer granules than fria-
bility measurements did.
3.2. Ibuprofen loading effect on granule properties
For both Kenwood and Mi-Pro granules, pycnometric density
values varied as a function of ibuprofen content (Table 2) and were
strictly in accordance with theoretical values calculated from
respective pycnometric densities of CaP (3.04 g cm3) and ibupro-
fen (1.11 g cm3) (Fig. 1). Consequently, pycnometric density mea-
surements could be proposed as a method for estimating ibuprofen
content in the concentration range considered in this study.
Non-loaded Kenwood granules were less circular than Mi-Pro
pellets, and circularity determined byMorphologi G3 remained un-
changed after the loading procedure (Table 2). These results are in
agreement with the SEM images (Fig. 2). It should be noted that the
circularity value of granules loaded with 46% ibuprofen was de-
creased, especially in the case of Mi-Pro pellets, probably due to
the formation of an irregular ibuprofen coating outside the
granules.
Fig. 3 presents the rupture strength as a function of the drug
content. Results showed that ibuprofen loading increased the
mechanical strength of the two types of granules. Moreover, for
all ibuprofen contents, Mi-Pro pellets presented a higher cohesion
than Kenwood granules: up to 22% ibuprofen content, they were
twice as resistant. Beyond this drug content, the slope of the curve
was more important, indicating a significant increase in strength
with content of drug substance. In this second zone, the evolution
was quite similar for the two types of granules, and Mi-Pro pellets
remained more resistant whatever the drug content. Results ob-
tained for 46% ibuprofen content should be considered carefully,
as granules tended to stick and thus presented an irregular and
agglomerated shape. Two hypotheses regarding the location of ibu-
profen deposited might be proposed to explain the two regions
highlighted on the rupture strength curve: (i) pores could be pro-
gressively filled up to a threshold for which the whole porous vol-
ume would be completely saturated, and the additional ibuprofen
could only be deposited onto granules; (ii) the granule surface
Table 1
Physicochemical properties of non-loaded calcined granules.
Properties Kenwood Mi-Pro
Morphology
Circularity coefficient 0.76 0.83
dpycno (g cm3) 3.04 3.04
dbulk (g cm3) 0.55 0.71
dpacked (g cm3) 0.79 0.78
Sspe (m2 g1) 5.91 5.69
Pellet porosity (%) 61.2 57.7
Friability (%) 21.3 12.1
Rupture strength (mN) 298 ± 97 750 ± 225
Table 2
Loaded granules physicochemical properties.
Ibuprofen content (%) Kenwood Mi-Pro
dpycno (g cm3) Circularity dpycno (g cm3) Circularity
0 3.04 0.69 ± 0.09 3.04 0.81 ± 0.07
1.75 2.84 ND 2.95 ND
3.5 2.87 0.71 ± 0.07 2.89 0.80 ± 0.07
7 2.73 0.68 ± 0.09 2.71 0.78 ± 0.08
12.5 2.50 0.71 ± 0.07 2.50 0.79 ± 0.08
22 2.18 0.72 ± 0.07 2.17 0.78 ± 0.08
36 1.85 0.72 ± 0.08 1.86 0.77 ± 0.10
46 ND 0.68 ± 0.11 ND 0.74 ± 0.09
ND, not determined.
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Fig. 1. Evolution of pycnometric density as a function of ibuprofen content.
could first be coated with the drug substance, and pores would be
progressively filled with the increase in quantity deposited.
In both cases, the second step would explain the significant con-
solidation of the granules.
NIR-CI was performed in order to investigate the location of
ibuprofen and to try to determine the sequence of drug deposition.
Spectral analyses of the raw materials confirmed that calcium
phosphate does not absorb NIR radiation. Ibuprofen presents a
complex spectrum with a number of specific absorption bands,
such as a sharp band seen in the region 2110–2210 nm (Fig. 4).
Consequently, it was possible to integrate the area under the curve
(AUC) in this region, which was indicative of the quantity of ibu-
profen deposited on granule surfaces for the various ibuprofen
contents and the two types of pellets. AUC values increased with
the increase in drug content (Fig. 5) and were similar for the two
granulation processes up to 22%. Beyond this drug content, AUC
strongly increased for both types of granules, but the values were
higher in the case of Mi-Pro pellets. However, pycnometric density
measurements showed that granules were loaded with the same
ibuprofen quantity. One hypothesis to explain this difference was
related to the location of ibuprofen. In accordance with their higher
sphericity, Mi-Pro pellets may be more regularly coated, whereas
the irregular shape of Kenwood granules would induce areas of
preferential accumulation of ibuprofen. Another hypothesis would
be the more important intrusion of ibuprofen into the pores of
Kenwood granules, correlated to their higher porosity, leading to
a lower surface content, as measured in the NIR spectra. From
36% up to 46% of drug content, the variation in the AUC value
was not significant, indicating that a similar thickness of ibuprofen
was measured on the granule surfaces. However, it should be no-
ticed that, as for the granule crush test results, the AUC value
determined for granules loaded with 46% ibuprofen should be con-
sidered only as a tendency, owing to the propensity of the granules
to adhere to each other. NIR-CI performed on granule cross section
(Fig. 6) highlighted the presence of ibuprofen inside and outside
both types of granules, and confirmed the more regular coating
in the case of Mi-Pro pellets, as previously assumed.
The increase in AUC values over all the drug contents, and espe-
cially over 22%, suggesting an ibuprofen coating, could explain the
strengthening of the granule. The higher breaking force of Mi-Pro
pellets previously reported could be maintained by the more regu-
lar ibuprofen deposition onto these spheroids. Morphological anal-
ysis showed a slight increase in the circularity value with
ibuprofen content for Kenwood granules, owing to the initial rela-
tively irregular shape. In contrast, circularity values, relatively high
for unloaded Mi-Pro pellets, decreased slightly with ibuprofen
deposition. However, these variations were not sufficient to distin-
guish clearly between the two types of loaded granules and justi-
fied further mercury porosimetry investigation to gather
information on the pore filling.
Fig. 2. SEM observations of loaded (a) Kenwood granules and (b) Mi-Pro pellets.
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Fig. 3. Evolution of the rupture strength as a function of the ibuprofen content.
Mercury cumulative porograms are given for drug contents
from 0 to 36% (Fig. 7). They show the presence of a main pore range
3–400 nm for Kenwood granules and 3–300 nm for Mi-Pro pel-
lets, and a second intrusion range corresponding roughly to pore
size diameters between 400 and 10,000 nm for Kenwood granules
and 300–10,000 nm for Mi-Pro pellets. Thereafter, the main pore
range was called ‘‘small pores” and the second ‘‘large pores”. The
evolution of the volume of these two pore ranges as a function of
the ibuprofen content is shown on Fig. 8. The higher pellet porosity
of unloaded Kenwood granules, as previously noted (see Section
3.1), resulted from the higher proportion of ‘‘small pores”. Indeed,
at 0% ibuprofen content, the porous volume of ‘‘small pores”
equaled 0.43 mL g1 for Kenwood granules, whereas it was
0.34 mL g1 for Mi-Pro pellets. ‘‘Large pores” volumes were similar
for the two types of granules. The decrease in the porous volume
from the first drug contents highlighted, as shown by the NIR spec-
troscopy (Fig. 5), that ibuprofen deposition occurred not only on
the surface, but also into granule pores, regardless of the granula-
tion process. Fig. 8 also indicates that, for 36% ibuprofen, both
porosities were totally filled for both types of granules. Moreover,
drug loading with increasing ibuprofen contents induced a linear
decrease in the ‘‘large pore” volumes of both types of granules.
For Kenwood granules, ‘‘small pore” volumes decreased linearly
over all the ibuprofen content range studied, whereas the evolu-
tion of Mi-Pro pellet volume presented two stages. From 0% to
22%, the pore volume decreased in the same manner as for
1200 1400 1600 1800 2000 2200 2400
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
0.55
Wavelength (nm)
Ab
so
rb
an
ce
ibuprofen
calcium phosphate
Fig. 4. NIR spectrum of granule constituents.
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Kenwood granules; above 22%, the available pore volume was low-
er, and the slope of the evolution was reduced. Comparison of Figs.
5 and 8 indicates that, when most of pellet porosity (<0.20 mL g1)
was filled, additional ibuprofen deposited onto granule surfaces. As
both types of granules were loaded with the same amount of ibu-
profen, the quantity of ibuprofen deposited onto Kenwood gran-
ules was lower than that for Mi-Pro pellets, owing to their higher
initial pellet porosity. Therefore, the higher ibuprofen coating on
‘‘fully filled” granules induced the high increase in mechanical
strength, especially in the case of Mi-Pro pellets (Fig. 3).
4. Conclusion
The aim of this work was to study the impact of the location of
drug substance on the physicochemical and mechanical properties
of calcium phosphate pellets. Granules produced by two granula-
tion processes and loaded with seven ibuprofen contents were
compared.
Unloaded granule characteristic study demonstrated higher
sphericity and mechanical strength (evaluated by friability and
rupture strength) of Mi-Pro pellets. A bimodal pore size distribu-
tion was observed for both types of granules, but Kenwood gran-
ules presented a slightly higher total porous volume, explaining
their lower rupture strength.
Various characterization techniques were combined to inves-
tigate ibuprofen-loaded granules and to try to relate the evolu-
tion of their physico-technological properties to drug substance
content and location. Thus, it was shown that the whole ibupro-
fen quantity could be loaded onto both types of granules. More-
over, the drug content could be estimated from pycnometric
density measurements. The cross-analysis of surface composition
and pore volumes as a function of the drug content highlighted
that, from the first drug contents, ibuprofen deposited simulta-
neously on the surface and inside the pores. From 22% of drug
substance, pore filling was almost completed, and additional ibu-
profen coated the granule surfaces. As revealed by the unit crush
tests, the loading enhanced granule mechanical strength, espe-
cially beyond 22%. This strengthening is favorable to further
implantation into bone defect cavities, as porous bioceramic
applications are often limited by the low resistance of the prod-
ucts. Nevertheless, these initial characteristics might evolve in an
osseous environment and should be considered in conjunction
with bone colonization kinetics.
In correlation with their further application in bone implant and
drug delivery systems, the bioactivity of these loaded pellets must
be evaluated in comparison with unfilled granules, as the presence
of ibuprofen on the bioceramics could modify blood liquid ex-
changes, cell adhesion and consequently osteoconduction, and
the in vivo drug release kinetics must be determined.
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Fig. 7. Cumulative porograms of (a) Kenwood and (b) Mi-Pro granules, as a function of ibuprofen content.
Finally, an alternative loading method using supercritical fluids
is under investigation in order to avoid the use of solvent, which
prevents the transposition of the present fabrication technique
on an industrial scale.
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